Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Shockwave Medical stock (SWAV)

Buy Shockwave Medical stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Shockwave Medical is a medical devices business based in the US. Shockwave Medical shares (SWAV) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.00 – the same closing value as a week prior. Shockwave Medical employs 1,468 staff and has a trailing 12-month revenue of around $788 million.

Our top picks for where to buy Shockwave Medical stock

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • Complimentary access to a financial planner and automated investing

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Shockwave Medical stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – SWAV. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Shockwave Medical stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product USFST Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Zero-commission stocks, ETFs and options, with no options per-contract fees. Plus, a no-advisory-fee robo-advisor and complimentary access to financial planners.
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
eToro
Finder Score: 4 / 5: ★★★★★
EXCLUSIVE
eToro
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.9%
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
No commission stock, ETF and options trades, with 4.9% interest on your options account balance and no options contract fees.
Robinhood
Finder Score: 4.4 / 5: ★★★★★
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.5%
Get a free stock
Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Shockwave Medical stock price (NASDAQ: SWAV)

Use our graph to track the performance of SWAV stocks over time.

Shockwave Medical shares at a glance

Information last updated 2024-07-21.
Latest market close$0.00
52-week range$157.00 - $334.90
50-day moving average $326.86
200-day moving average $241.38
Wall St. target price$324.27
PE ratio 78.7647
Dividend yield N/A
Earnings per share (TTM) $4.25

Is it a good time to buy Shockwave Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Shockwave Medical price performance over time

Historical closes compared with the close of $0 from 2024-06-11

1 week (2024-09-29) N/A
1 month (2024-09-06) N/A
3 months (2024-07-06) N/A
6 months (2024-04-10) -100.00%
1 year (2023-10-10) -100.00%
2 years (2022-10-10) -100.00%
3 years (2021-10-08) 199.61
5 years (2019-10-10) 29.4

Is Shockwave Medical stock undervalued or overvalued?

Valuing Shockwave Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Shockwave Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Shockwave Medical's P/E ratio

Shockwave Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 79x. In other words, Shockwave Medical shares trade at around 79x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Shockwave Medical's EBITDA

Shockwave Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $180.3 million.

The EBITDA is a measure of a Shockwave Medical's overall financial performance and is widely used to measure a its profitability.

Shockwave Medical financials

Revenue TTM $788 million
Operating margin TTM 19.38%
Gross profit TTM $424.7 million
Return on assets TTM 8.68%
Return on equity TTM 24.73%
Profit margin 20.75%
Book value $20.04
Market Capitalization $12.6 billion

TTM: trailing 12 months

Shockwave Medical share dividends

We're not expecting Shockwave Medical to pay a dividend over the next 12 months.

Shockwave Medical share price volatility

Over the last 12 months, Shockwave Medical's shares have ranged in value from as little as $157 up to $334.9. A popular way to gauge a stock's volatility is its "beta".

SWAV.US volatility(beta: 0.88)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Shockwave Medical's is 0.879. This would suggest that Shockwave Medical's shares are less volatile than average (for this exchange).

Shockwave Medical overview

Shockwave Medical, Inc. , a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors.

Frequently asked questions

What percentage of Shockwave Medical is owned by insiders or institutions?
Currently 1.195% of Shockwave Medical shares are held by insiders and 98.726% by institutions.
How many people work for Shockwave Medical?
Latest data suggests 1,468 work at Shockwave Medical.
When does the fiscal year end for Shockwave Medical?
Shockwave Medical's fiscal year ends in December.
Where is Shockwave Medical based?
Shockwave Medical's address is: 5403 Betsy Ross Drive, Santa Clara, CA, United States, 95054
What is Shockwave Medical's ISIN number?
Shockwave Medical's international securities identification number is: US82489T1043
What is Shockwave Medical's CUSIP number?
Shockwave Medical's Committee on Uniform Securities Identification Procedures number is: 82489T104

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site